Takeda.us

Takeda. Research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating...

Never miss Takeda.us updates: Start reading the news feed of Takeda right away! This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Takeda.us popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Takeda

Subscribe to related news

FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension, First and only fixe...
via tap

Deerfield, Ill., December 20, 2011, and Osaka, Japan, December 21, 2011 – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced today that the U.S. Food and Drug Administration...
U.S. Food and Drug Administration (FDA) Delays Review of Takeda’s Investigational Type 2 Diabetes Therapies, Alogliptin ...
via tpna

DEERFIELD, Ill. and Osaka, Japan, November 18, 2011 – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., today announced that the company received notification from...
Takeda Ventures, Inc.
via chi

Takeda Ventures Inc. (TVI) is the corporate venture arm of Takeda Pharmaceutical Company Limited (TPC) a world-class pharmaceutical company and the largest in Japan. A wholly-owned subsidiary of Takeda America Holdings, Inc., TRI started operations in...
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate?
via thetradingreport

There are many investors who believe that the stock market is currently overvalued. To a great extent, they may be correct as there is a lot of excessive valuation to be found in various segments of the market. However, as I believe it is a market of...
Takeda is buying Ariad Pharmaceuticals in a $5.2 billion deal (ARIA)
via businessinsider

The Japanese pharmaceutical company Takeda is buying Cambridge, Massachussets-based Ariad Pharmaceuticals for $24 a share. The deal is valued at about $5.2 billion and expected to close in February. "This is a very exciting time for Takeda as we will...

Takeda.us popular pages

United States | Home

Welcome to Takeda in the U.S. We’re the largest life sciences employer in the state of Massachusetts with our global hub and research center in Cambridge, MA., and have sites across the U.S. in 39 sta...
Takeda - Better Health, Brighter Future

Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Ta...

United States | Home

United States | Home United States# United States Welcome to Takeda in the U.S. We’re the largest life sciences employer in the state of Massachusetts with our global hub and research center in Cambri...